Stockscreener 앱 받기
2.5028
9.29%
0.2128
시간 외 거래:
2.50
-0.0028
-0.11%
전일 마감가:
$2.29
열려 있는:
$2.28
하루 거래량:
36,976
Relative Volume:
1.05
시가총액:
$10.32M
수익:
$1.02M
순이익/손실:
$-10.36M
주가수익비율:
-0.402
EPS:
-6.2265
순현금흐름:
$-8.76M
1주 성능:
-2.61%
1개월 성능:
-13.40%
6개월 성능:
-38.81%
1년 성능:
-5.91%
1일 변동 폭
$2.25
$2.6099
1주일 범위
$2.22
$2.63
52주 변동 폭
$1.71
$6.78
SINTX 테크놀로지스 Stock (SINT) Company Profile
명칭
Sintx Technologies Inc
전화
801-839-3516
주소
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.5028 | 9.44M | 1.02M | -10.36M | -8.76M | -6.2265 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
SINTX 테크놀로지스 Stock (SINT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-12 | 개시 | Ascendiant Capital Markets | Buy |
SINTX 테크놀로지스 주식(SINT)의 최신 뉴스
Earnings Update: What is the PEG ratio of Sintx Technologies IncMarket Risk Report & Technical Confirmation Alerts - baoquankhu1.vn
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - Orthopedics This Week
SINTX completes first human implant, names new president By Investing.com - Investing.com Australia
Sintx Technologies 2025 10‑K: Revenue $1.018M, Net Loss $10.364M - TradingView
SINTX completes first human implant, names new president - Investing.com
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Sintx Technologies (SINT) to Release Quarterly Earnings on Monday - Defense World
SINTX Technologies: Advanced Silicon Nitride Ceramics for Biomedical, Technical, and Antipathogenic Applications 72 - Minichart
SINTX Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
SINTX Technologies (NASDAQ: SINT) outlines 2025 losses, cash and silicon nitride strategy - Stock Titan
SINTX completes first surgery with foot and ankle implant system By Investing.com - Investing.com India
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Orthopedics This Week
SINTX Technologies (SINT) Achieves Milestone with First Surgical Use of New System - gurufocus.com
SINTX completes first surgery with foot and ankle implant system - Investing.com
Sintx Technologies announces first-in-human surgery using FDA-cleared Sinaptic® Foot & Ankle Implant - marketscreener.com
A new foot implant reaches its first patient after FDA clearance - stocktitan.net
Sintx Technologies (SINT) president granted 107,143 RSUs under 2025 equity plan - Stock Titan
SINT PE Ratio & Valuation, Is SINT Overvalued - Intellectia AI
Revenue of Sintx Technologies, Inc. from 2020 to 2024 - Statista
SINTX Technologies Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Published on: 2026-03-11 05:25:53 - baoquankhu1.vn
Sintx Technologies director Lyons buys shares worth $24,092 By Investing.com - Investing.com South Africa
Sintx Technologies director Lyons buys shares worth $24,092 - Investing.com
Director Lyons adds 8,292 Sintx Technologies (SINT) shares in open-market buys - Stock Titan
Earnings Beat: What is the PEG ratio of Sintx Technologies Inc2025 Winners & Losers & Free Reliable Trade Execution Plans - baoquankhu1.vn
SINTX focuses on filament and partnerships: New president to bring SiN/PEEK into 3D production - 3Druck.com
SINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SINTX Technologies names Ryan Elmore President to drive commercial expansion of SiN biomaterials - VoxelMatters
Published on: 2026-03-02 05:18:20 - baoquankhu1.vn
SINTX Technologies signs with Evonik to produce SiN/PEEK compound for 3D printed implants - VoxelMatters
SINTX Technologies acquires SiNAPTIC Surgical assets to enter foot and ankle fusion market - voxelmatters.com
SINT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SINTX Technologies Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Insider Buying: Jay Moyes Acquires Additional Shares of SINTX Te - GuruFocus
Sintx Technologies director Moyes buys $2910 in shares - Investing.com
What is the PEG ratio of Sintx Technologies Inc.Trade Volume Summary & High Accuracy Trade Alerts - mfd.ru
Is Sintx Technologies Inc. (1110) stock a buy for dividend portfoliosStop Loss & Reliable Intraday Trade Plans - mfd.ru
Sintx Technologies director Anderson buys $9,060 in stock - Investing.com Australia
Sintx Technologies director Anderson buys $9,060 in stock By Investing.com - Investing.com South Africa
Insider Buying: Mark Anderson Acquires Additional Shares of SINTX Technologies Inc (SINT) - GuruFocus
Sintx Technologies Appoints Ryan Elmore as New President - The Globe and Mail
SINTX Technologies appoints Ryan Elmore as president - Investing.com Nigeria
Sintx Technologies, Inc. Announces Cessation of Eric Olson as President, Effective March 16, 2026 - marketscreener.com
Sintx Technologies, Inc. Appoints Ryan Elmore as President, Effective March 16, 2026 - marketscreener.com
SINT Appoints Ryan Elmore as President, Effective March 2026 - GuruFocus
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms - The Manila Times
Treasury Yields: Is National Healthcare Properties Inc stock risky to hold nowEarnings Overview Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
SINTX 테크놀로지스 (SINT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
SINTX 테크놀로지스 주식 (SINT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lyons Christopher Michael | Director |
Feb 25 '26 |
Buy |
2.96 |
758 |
2,244 |
758 |
| MOYES JAY M | Director |
Feb 23 '26 |
Buy |
2.91 |
1,000 |
2,910 |
4,000 |
| Anderson Mark Lewis | Director |
Feb 18 '26 |
Buy |
3.02 |
3,000 |
9,060 |
18,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Dec 08 '25 |
Buy |
4.26 |
8,200 |
34,896 |
201,067 |
| Honigblum Gregg R. | Chief Investment Officer |
Dec 05 '25 |
Buy |
3.93 |
65,000 |
255,350 |
139,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Nov 07 '25 |
Buy |
3.19 |
10,000 |
31,900 |
74,000 |
| Olson Eric K. | President and CEO |
Oct 20 '25 |
Buy |
3.40 |
5,800 |
19,720 |
30,775 |
| MOYES JAY M | Director |
Aug 26 '25 |
Buy |
3.59 |
3,000 |
10,756 |
3,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Aug 26 '25 |
Buy |
3.70 |
50,000 |
185,000 |
64,000 |
| Olson Eric K. | President and CEO |
Aug 22 '25 |
Buy |
3.58 |
10,475 |
37,470 |
24,975 |
2.03%
자본화:
|
볼륨(24시간):